Sources | Names Used |
---|---|
CTRPv2 | triazolothiadiazine |
PharmacoGx | triazolothiadiazine |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | XPO7 | CTRPv2 | pan-cancer | AAC | 0.15 | 6e-07 |
mRNA | DFFB | CTRPv2 | pan-cancer | AAC | 0.17 | 6e-07 |
mRNA | HMGXB4 | CTRPv2 | pan-cancer | AAC | 0.15 | 6e-07 |
mRNA | YARS | CTRPv2 | pan-cancer | AAC | 0.16 | 6e-07 |
mRNA | UBE2O | CTRPv2 | pan-cancer | AAC | 0.16 | 6e-07 |
mRNA | MIS18A | CTRPv2 | pan-cancer | AAC | 0.16 | 6e-07 |
mRNA | CHMP4B | CTRPv2 | pan-cancer | AAC | -0.16 | 6e-07 |
mRNA | HNRNPC | CTRPv2 | pan-cancer | AAC | 0.16 | 6e-07 |
mRNA | SMARCA5 | CTRPv2 | pan-cancer | AAC | 0.16 | 6e-07 |
mRNA | CDC25A | CTRPv2 | pan-cancer | AAC | 0.17 | 6e-07 |